Table 2.

Primary analysis predicting intervention effects on use of tobacco products at follow-up, among participants aged <21 years

Tobacco product use at baseline	Intervention arm	Tobacco product use at 3 months OR (95% CI)
		Non-use	Regular dual or poly use
Any regular tobacco mono use (Ref.)	BTI+AG vs CTA	2.13 (1.02–4.46)	1.63 (0.54–4.89)
	AG vs CTA	2.07 (0.81–5.26)	1.54 (0.54–4.40)
Regular dual or poly tobacco use	BTI+AG vs CTA	0.36 (0.15–0.91)	0.34 (0.12–0.97)
	AG vs CTA	0.46 (0.15–1.40)	0.37 (0.12–1.09)

Bold indicates statistical significance at p<0.05.